GABAergic control of basal forebrain cholinergic neurons and memory
- PMID: 2029342
- DOI: 10.1016/s0166-4328(05)80037-3
GABAergic control of basal forebrain cholinergic neurons and memory
Abstract
The involvement of the GABAergic innervation of basal forebrain neurons in the rats' conditional visual discrimination performance was examined. Performance in such a task is based on the subjects's ability to retrieve information about response rules, and previous experiments have demonstrated that basal forebrain lesions interfere with this ability. Following the acquisition of the task, chronic guide cannulae were stereotaxically implanted into the substantia innominata of both hemispheres, and the animals were retrained. Administration of the GABAA-agonist muscimol into the substantia innominata (0, 25, 50 ng/0.5 microliters/hemisphere) dose-dependently decreased the number of correct responses, increased the number of errors of omission, increased response latency, but did not affect side bias. Systemic co-administration of the cholinesterase inhibitor physostigmine (0, 0.1, 0.2 mg/kg; i.p.) exclusively interacted with the effects of muscimol on correct responding. Specifically, physostigmine dose-dependently intensified and attenuated the muscimol-induced reduction in correct responding. Although it cannot be excluded that alternative neuronal mechanisms were involved in the mediation of the effects of muscimol and their interaction with physostigmine, these findings support previous evidence indicating that the activity of basal forebrain cholinergic neurons is controlled by a GABAergic input, and that this neuronal link is involved in mnemonic processing.
Similar articles
-
Disruptive effects of muscimol infused into the basal forebrain on conditional discrimination and visual attention: differential interactions with cholinergic mechanisms.Psychopharmacology (Berl). 1992;107(4):541-50. doi: 10.1007/BF02245269. Psychopharmacology (Berl). 1992. PMID: 1603898
-
Pharmacological manipulations of the substantia innominata-cortical cholinergic pathway.Neurosci Lett. 1984 Sep 28;51(1):99-103. doi: 10.1016/0304-3940(84)90269-6. Neurosci Lett. 1984. PMID: 6151154
-
The effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on the acquisition and retention of a conditional visual discrimination: implications for cholinergic hypotheses of learning and memory.Neuroscience. 1987 Aug;22(2):441-69. doi: 10.1016/0306-4522(87)90346-0. Neuroscience. 1987. PMID: 3670594
-
Failure of a chlordiazepoxide to reproduce the behavioral effects of muscimol administered into the basal forebrain.Behav Brain Res. 1992 Apr 10;47(2):202-5. doi: 10.1016/s0166-4328(05)80127-5. Behav Brain Res. 1992. PMID: 1317181
-
Nucleus basalis magnocellularis and attention: effects of muscimol infusions.Behav Neurosci. 1993 Dec;107(6):1031-8. doi: 10.1037//0735-7044.107.6.1031. Behav Neurosci. 1993. PMID: 8136056
Cited by
-
Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum.Exp Brain Res. 1993;93(3):399-411. doi: 10.1007/BF00229356. Exp Brain Res. 1993. PMID: 7686107
-
Opposing Roles of Cholinergic and GABAergic Activity in the Insular Cortex and Nucleus Basalis Magnocellularis during Novel Recognition and Familiar Taste Memory Retrieval.J Neurosci. 2016 Feb 10;36(6):1879-89. doi: 10.1523/JNEUROSCI.2340-15.2016. J Neurosci. 2016. PMID: 26865612 Free PMC article.
-
The Insula and Taste Learning.Front Mol Neurosci. 2017 Nov 3;10:335. doi: 10.3389/fnmol.2017.00335. eCollection 2017. Front Mol Neurosci. 2017. PMID: 29163022 Free PMC article. Review.
-
Attenuation of muscarinic receptor blockade-induced impairment of spatial delayed alternation performance by the triazole MDL 26,479.Psychopharmacology (Berl). 1992;109(1-2):223-30. doi: 10.1007/BF02245504. Psychopharmacology (Berl). 1992. PMID: 1365661
-
Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy.Exp Clin Psychopharmacol. 2013 Oct;21(5):416-25. doi: 10.1037/a0033668. Exp Clin Psychopharmacol. 2013. PMID: 24099361 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical